| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5a95d4999542f2d9fa147bfed0e90cf |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate |
1993-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba90e90680a3c8b22d94a150ae66ec97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72cc840323fad6db69a590ad43619e2a |
| publicationDate |
1993-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9324120-A1 |
| titleOfInvention |
USE OF (E)-2-(p-FLUOROPHENETHYL)-3-FLUOROALLYLAMINE IN THE TREATEMENT OF ALZHEIMER'S DISEASE |
| abstract |
The present invention relates to a method of treatment for Alzheimer's disease in a patient in need thereof comprising administering to said patient a therapeutically effective amount of (E)-2-(p-fluorophenethyl)-3-fluoroallylamine or a pharmaceutically acceptable salt thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9610003-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5679854-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007120528-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0872465-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0872465-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9508325-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5488188-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2343064-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007120528-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5599986-A |
| priorityDate |
1992-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |